In terms of mechanism, METTL3 plays an oncogenic role by methylating the BCL-2, PTEN, and c-MYC mRNAs, facilitating their translation, leading to the inhibition of cell differentiation and apoptosis, thus promoting the progression of AML [88]. The gene discussed is MYC; the disease is acute myeloid leukemia.